Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries

BACKGROUND: In 2009, the Global Fund to Fight AIDS, Tuberculosis and Malaria established the Affordable Medicines Facility-malaria (AMFm) in order to increase access to quality-assured artemisinin combination therapy (QAACT). AMFm Phase 1, which includes nine pilot programmes in eight countries, was...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Ben, Ladner, Joel, Sams, Kelley, Tekinturhan, Ebru, de Korte, Donald, Saba, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637826/
https://www.ncbi.nlm.nih.gov/pubmed/23607504
http://dx.doi.org/10.1186/1475-2875-12-135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637826/
https://www.ncbi.nlm.nih.gov/pubmed/23607504
http://dx.doi.org/10.1186/1475-2875-12-135

Ejemplares similares